Moderna COVID-19 vaccine approved by MHRA for use in adolescents, MHRA

This extension to the current UK approval of the Moderna (Spikevax) vaccine covers use in 12- to 17-year-olds. The vaccine was authorised for use in 12-17 year olds in Northern Ireland on 23 July via the approval from the European Medicines Agency.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news